Cellectar Biosciences Inc (CLRB)
3.35
+0.19
(+6.01%)
USD |
NASDAQ |
May 02, 15:23
Cellectar Biosciences Total Return Level: 3.16 for May 1, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 01, 2024 | 3.16 |
April 30, 2024 | 3.09 |
April 29, 2024 | 3.10 |
April 26, 2024 | 3.03 |
April 25, 2024 | 3.02 |
April 24, 2024 | 3.06 |
April 23, 2024 | 3.11 |
April 22, 2024 | 3.19 |
April 19, 2024 | 3.03 |
April 18, 2024 | 3.04 |
April 17, 2024 | 3.21 |
April 16, 2024 | 3.31 |
April 15, 2024 | 3.32 |
April 12, 2024 | 3.51 |
April 11, 2024 | 3.71 |
April 10, 2024 | 3.49 |
April 09, 2024 | 3.73 |
April 08, 2024 | 3.81 |
April 05, 2024 | 3.76 |
April 04, 2024 | 3.72 |
April 03, 2024 | 3.98 |
April 02, 2024 | 3.99 |
April 01, 2024 | 3.92 |
March 28, 2024 | 3.98 |
March 27, 2024 | 3.635 |
Date | Value |
---|---|
March 26, 2024 | 3.85 |
March 25, 2024 | 3.87 |
March 22, 2024 | 4.05 |
March 21, 2024 | 3.87 |
March 20, 2024 | 3.73 |
March 19, 2024 | 3.78 |
March 18, 2024 | 3.35 |
March 15, 2024 | 3.48 |
March 14, 2024 | 3.38 |
March 13, 2024 | 3.54 |
March 12, 2024 | 3.63 |
March 11, 2024 | 3.77 |
March 08, 2024 | 4.00 |
March 07, 2024 | 4.07 |
March 06, 2024 | 4.00 |
March 05, 2024 | 4.05 |
March 04, 2024 | 4.24 |
March 01, 2024 | 4.20 |
February 29, 2024 | 3.92 |
February 28, 2024 | 3.94 |
February 27, 2024 | 3.88 |
February 26, 2024 | 3.49 |
February 23, 2024 | 3.34 |
February 22, 2024 | 3.35 |
February 21, 2024 | 3.275 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.27
Minimum
Dec 19 2022
31.70
Maximum
Feb 18 2020
10.05
Average
8.65
Median
Oct 04 2021
Total Return Level Benchmarks
Perspective Therapeutics Inc | 1.70 |
Eli Lilly and Co | 2235.83 |
Actinium Pharmaceuticals Inc | 7.78 |
Bristol-Myers Squibb Co | 176.90 |
Altimmune Inc | 13.30 |